CDW vs LXEO · P/E 22, rev $12.25B vs $147.7M cap
CDW Corp (CDW) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported CDW revenue for 2026-06-30 was $12.25B. Net income was $509.8M. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
LXEO does not have a complete income-statement cache yet.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the CDW and LXEO stock pages for the full models.
Not investment advice.